impact factor, citescore
logo
 

Letters to the Editor

 

Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

 

  1. University of Siena, Italy.
  2. Schlosspark-Klinik University of Medicine, Berlin, Germany.
  3. Bristol-Myers Squibb, Rueil-Malmaison, France.
  4. Excelya, Boulogne-Billancourt, France.
  5. A.O.U. Città della Salute e della Scienza di Torino, Italy.
  6. Bristol-Myers Squibb, Rueil-Malmaison, France.
  7. University Hospital, Heidelberg, Germany.
  8. Unit of Rheumatology, Azienda Ospedaliera Bianchi- Melacrino-Morelli, Reggio Calabria, Italy.
  9. Unità Operativa di Reumatologia, Presidio Ospedaliero Vito Fazzi, San Cesario di Lecce, Italy.
  10. University of Erlangen-Nuremberg, Nuremberg, Germany.
  11. Bristol-Myers Squibb, Rome, Italy. giovanni.patane@bms.com

CER10419
2018 Vol.36, N°5
PI 0935, PF 0936
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 29600933 [PubMed]

Received: 16/03/2017
Accepted : 11/09/2017
In Press: 21/03/2018
Published: 26/09/2018

Rheumatology Article